awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48375673-89052869-66D8-4B26-B9BC-1D6250B432BD
Q48375673-89052869-66D8-4B26-B9BC-1D6250B432BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48375673-89052869-66D8-4B26-B9BC-1D6250B432BD
The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements : Current Debate.
P2860
Q48375673-89052869-66D8-4B26-B9BC-1D6250B432BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48375673-89052869-66D8-4B26-B9BC-1D6250B432BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d4bfab4b6af8d9105bb6a7b5657d387db27b759
P2860
Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure.